Overview
OHRPP is in the process of transitioning from one electronic system (webIRB) to another (BruinIRB). Depending on the type of initial application you need to submit, you will need to submit to one of these systems:
- Submissions accepted:
- Exempt
- Expedited
- Full Board
- webIRB Quick Reference Guides & Training Materials
- Submissions accepted:
- Submission accepted:
- UCLA relying on another IRB
- Emergency Use
- Humanitarian Use Device (HUD)
- Right to Try
- Expanded Access (Drug and Biologics and Device)
- BruinIRB Quick Reference Guides & Training Materials
- BruinIRB Protocol Templates
- Submission accepted:
Latest phase of the transition
All active UCLA relying on another IRB submissions in webIRB, without an open AM, PAR, or closure, has been migrated into BruinIRB as of April 15, 2023.
- You will receive a notification when your study is transferred to BruinIRB via email and documented in the webIRB study history. Migration Quick Guide
A majority of the information from webIRB has been migrated into BruinIRB. However, there are some new questions in BruinIRB that were not asked in webIRB. When you submit an amendment in the future, please complete those required fields.
If your study has not been migrated, this is because you have an open submission in webIRB. Please check that you do not have any open amendments or PARs in order for your study to be migrated. Once the open submission has either been withdrawn or External Review Accepted, then your study will be migrated that following week.
- You will receive a notification when your study is transferred to BruinIRB via email and documented in the webIRB study history. Migration Quick Guide
- Those with active webIRB accounts will have an active BruinIRB account on July 1, 2022.
Upcoming
- Phase 2 of BruinIRB TBD
- Additional Quick Reference Guides & Training Materials
If you have any questions regarding these submissions, please contact us at bruinirb@research.ucla.edu or (310) 825-5344.
BruinIRB Protocol Templates
BruinIRB requires all submissions to upload a protocol document rather than completing questions within the application. To assist in the new protocol requirement, OHRPP has created protocol templates that can be used for each submission. The protocol templates contain all the required information required for IRB review.
Protocol templates
- Reliance studies – please submit the protocol that is being used at all sites
- Emergency Use
- Humanitarian Use Device
- Right to Try
- Expanded Access – Please see OHRPP Guidance and Procedures: Use of Drugs and Biologics in Clinical Research and Treatment or OHRPP Guidance and Procedures: Use of Devices in Clinical Research and Treatment for required sponsor or FDA documents that will serve as a protocol.
Note: These protocol templates are also available within BruinIRB Library.